Every material Form 8-K Stryker filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Stryker said Spencer Stiles, currently Group President of Orthopaedics, will become President and Chief Operating Officer effective January 1, 2026, with responsibility for the company's global businesses, strategy and mergers and acquisitions. Dylan Crotty, now President of Instruments, will succeed Stiles as Group President, Orthopaedics on the same date.
Stiles becomes President and COO effective January 1, 2026, and will lead global businesses, strategy and M&A
Stiles's annualized base salary rises to $1,000,000 with a bonus target of 100% of base salary
Crotty becomes Group President, Orthopaedics effective January 1, 2026, with base salary rising to $700,000 and a bonus target of 85%
Board committee recommendation for February 2026 long-term incentive awards: about $6,000,000 for Stiles and about $3,000,000 for Crotty
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Stryker filing is on SEC EDGAR ↗. 8-K briefs of other companies →